Chemed (CHE) Projected to Post Earnings on Wednesday

Chemed (NYSE:CHE) is projected to release its Q2 2025 earnings data before the market opens on Wednesday, July 23rd. Analysts expect the company to announce earnings of $6.02 per share and revenue of $650.60 million for the quarter.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating the consensus estimate of $5.59 by $0.04. The firm had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a return on equity of 27.58% and a net margin of 12.40%. The firm’s revenue was up 9.8% compared to the same quarter last year. During the same period in the prior year, the business earned $5.20 EPS. On average, analysts expect Chemed to post $21 EPS for the current fiscal year and $23 EPS for the next fiscal year.

Chemed Stock Down 2.2%

CHE opened at $454.46 on Wednesday. The business has a 50 day moving average price of $540.00 and a two-hundred day moving average price of $560.08. The company has a market cap of $6.65 billion, a PE ratio of 22.14, a P/E/G ratio of 2.24 and a beta of 0.50. Chemed has a 52 week low of $453.72 and a 52 week high of $623.61.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.44%. The ex-dividend date was Thursday, May 29th. Chemed’s dividend payout ratio is presently 9.74%.

Analysts Set New Price Targets

Several analysts have commented on CHE shares. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Saturday, July 5th. Royal Bank Of Canada reissued an “outperform” rating and set a $640.00 target price (down from $674.00) on shares of Chemed in a research note on Monday, June 30th. Finally, Bank of America cut their target price on Chemed from $708.00 to $650.00 and set a “buy” rating for the company in a research note on Monday, June 30th.

Insider Buying and Selling

In related news, CEO Kevin J. Mcnamara sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $576.45, for a total value of $864,675.00. Following the completion of the transaction, the chief executive officer directly owned 101,197 shares of the company’s stock, valued at $58,335,010.65. This trade represents a 1.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Spencer S. Lee sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $577.99, for a total value of $866,985.00. Following the completion of the transaction, the executive vice president directly owned 14,627 shares of the company’s stock, valued at $8,454,259.73. The trade was a 9.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,500 shares of company stock valued at $2,598,450. Company insiders own 3.29% of the company’s stock.

Hedge Funds Weigh In On Chemed

A hedge fund recently raised its stake in Chemed stock. Geneos Wealth Management Inc. raised its stake in shares of Chemed Corporation (NYSE:CHE) by 330.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 99 shares of the company’s stock after buying an additional 76 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Chemed were worth $61,000 at the end of the most recent reporting period. Institutional investors own 95.85% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.